Dec 4, 2019: Thornhill Medical Participates in the 23 Country, 2019 European African Military Nursing Exchange, Focused on Current Military Medical Readiness, Global Healthcare Impacts and Disaster Response Capabilities and Challenges
RAMSTEIN AIR BASE, Germany – Representatives from 23 countries around Europe and Africa gathered at Ramstein Air Base, Germany, this week to share and collaborate during the 2019 European African Military Nursing Exchange.
The 4-day event brought together nurses and medical professionals to present and share best practices, lessons learned and innovative health care practices pertaining to various military nursing specialties.
Oct 18, 2019: Made-in-Canada Technology may Help to Take Nobel Medicine Prize Research from Test Tube to Patient Bedside
Thornhill Medical has a patented technology that may have direct application for the research findings of the 2019 Nobel Prize for Medicine winners.
In Sweden on October 7, three international scientists were awarded the nearly US$1 million prize for their work showing how cells sense low oxygen levels and the many ways the body’s organs change to adapt. The trio “revealed the mechanism for one of life’s most adaptive processes” the Nobel committee said.
TORONTO – It’s portable, spurns electrical wires, batteries and complex AI algorithms and according to its inventor has the potential to revolutionize treatment of carbon monoxide (CO) poisoning. The FDA and Health Canada-approved Clearmate developed by Ontario-based Thornhill Medical Inc. resulted from company co-founder Joe Fisher’s observations while studying ways to regulate CO2 in his science lab.
May 30, 2019: Thornhill Medical Technology, Investigative Tool RespirAct™ Gas Control System, Contributes to International Team led by Scientists from Lawson Health Research Institute and Cedars-Sinai Medical Center
London researchers are working with teams internationally to develop a non-invasive way to diagnose heart disease.
After extensive tests on dogs, researchers at Lawson Health Research Institute — the research arm of London’s hospitals – are getting ready to bring the new MRI-based diagnostic technique to human patients.
The U.S. Food and Drug Administration today allowed marketing of a new device, ClearMate, intended to be used in an emergency room setting to help treat patients suffering from carbon monoxide poisoning. The device uses a novel method for quickly removing carbon monoxide from the body by increasing a patient’s rate of breathing.